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1. Introduction 
Epidemiological studies report an increased rate of gastrointestinal diseases in subjects older 
than 65 years, and these diseases constitute one of the most frequent indications for medical 
consultation in this population (Pilotto, 2004). Oesophageal and gastroduodenal diseases, 
especially Helicobacter pylori (H. pylori) infection, are frequent in this population since they 
account for 40% of the total digestive pathologies in the elderly. Even if data in the literature 
report an increased prevalence of H. pylori infection in the elderly, clinical interest remains 
low. Only 56% of elderly patients hospitalized for peptic ulcers in the United States were 
tested for H. pylori infection, among whom only 73% were then treated (Ofman et al., 2000). 
However, studies report an increased rate of peptic ulcer disease (PUD) complications and 
mortality in older patients (1 per million in young adults aged 20 years to 200 per million 
after 70 years) (Younger&Duggan, 2002). This alarming finding has stimulated further 
studies on the pathophysiological and clinical aspects of H. pylori infection in the geriatric 
population. Indeed, recent data reported that H. pylori chronic infection plays a role in 
gastric aging, appetite regulation, and possibly extra-digestive diseases such as Alzheimer 
disease in the elderly. 
2. Epidemiology in the elderly 
The principal reservoir for H. pylori infection appears to be the human stomach, especially 
the antrum (Megraud, 2003). In developing countries, the oro-fecal route as well as the oro-
oral route coexists because of poor socioeconomic and hygienic conditions (Nurgalieva et 
al., 2002). In developed countries, the oro-fecal transmission has gradually disappeared, 
leaving the oro-oral route, which is secondary to vomiting and gastro-oesophageal reflux 
(Megraud, 2003). Even if socioeconomic progress has led to a decrease in the incidence of the 
infection in developed countries, the prevalence of H. pylori infection still remains high in 
people born at the beginning of the 20eth century. In fact, Gause-Nilsson et al. (Gause-
Nilsson et al., 1998) reported that when cohorts of 70 year old subjects born in 1901-1902 and 
1922 were compared, the latter cohort showed a significantly lower H. pylori positive 
serology. This difference in H. pylori prevalence may reflect changes in socioeconomic 
conditions. Epidemiologic studies on elderly people, with a mean age of  approximately 70 
years, reported a prevalence of nearly 60 percent in asymptomatic subjects (Pilotto et al., 
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1996; Regev et al., 1999) and more than 70 percent among the most elderly patients with 
gastrointestinal diseases (Pilotto, 2001; Pilotto&Salles, 2002). Other studies reported a high 
prevalence of H. pylori infection in the most elderly population, especially in 
institutionalized old people, with a prevalence ranging from 70 to 85 percent (Regev, Fraser, 
Braun, Maoz, Leibovici&Niv, 1999). These results can be explained by the mode of 
transmission of H. pylori (oro-fecal or oro-oral), taking into account the promiscuity and 
living conditions in an institution. Regev et al. showed that living in an institution increased 
the risk of H. pylori infection, the prevalence of the infection being positively correlated with 
the duration of stay (Regev et al., 1999). Nevertheless, even if prevalence increases with age, 
the prevalence curve appears to be flat and tends to decrease after 85 years (Pilotto&Salles, 
2002; Salles-Montaudon et al., 2002). Thus, Neri et al. showed that H. pylori infection passed 
from 70 to 50 percent after 90 years (Neri et al., 1996). Two hypotheses can explain this 
trend. The first hypothesis is an underestimation of H. pylori infection, because of frequent 
chronic atrophic gastritis and frequent current or previous use of antisecretory and 
antibiotic treatments in this frail population. In a previous work, we showed a lower 
prevalence of H. pylori infection (47.7%) than expected in hospitalized elderly people, which 
can be explained on one hand by the higher polymedication with repetitive antibiotherapies 
and on the other hand by more frequent gastric atrophic lesions which offers a less favorable 
ground for H. pylori (Salles-Montaudon et al. 2002). The second hypothesis is a premature 
death of H. pylori infected subjects due to various comorbidities, e.g., gastric cancer, peptic 
ulcer diseases (PUD) and possibly other diseases such as cardiovascular diseases. Based on 
the data from the PAQUID Cohort study (“Personnes Agées Quid?” which was designed to 
enrol and follow-up elderly subjects randomly selected in the South-Western France4), we 
recently evaluated the impact of H. pylori infection on the mortality rate in a population of 
subjects older than 65 years. The follow-up of 605 subjects over 15 years, after adjustment for 
age, gender, and cardiovascular comorbidity, showed that an H. pylori infection was not a 
risk factor for mortality (HR=1.2, 95% CI [0.94; 1.52]) (Salles et al.). 
3. H. pylori infection and peptic ulcer disease 
The elderly are particularly susceptible to peptic ulcer disease (PUD) and complications due 
to their higher H. pylori prevalence and use of non-steroidal anti-inflammatory drugs 
(NSAIDs) (Bhala&Newton, 2005; Chow et al., 1998; Jones&Hawkey, 2001). Even if it is well 
known that the incidence of gastric ulcers increases in elderly people, little is known about 
gastric mucosal healing alterations during ageing. Newton et al. reported that gastric ageing 
induces gastric frailty, characterized by a reduction in protective factors, i.e., mucus layer, 
prostaglandin levels, mucosal growth, and gastric blood flow, and a higher susceptibility to 
aggressive factors, i.e., NSAID and H. pylori infection (Newton, 2004). Age-related changes 
could occur as a result of increased exposure to exogenous factors, alterations in the 
secretion of endogenous aggressive factors, or changes in the production or repair of the 
mucus bicarbonate layer, the primary barrier against acid and pepsin digestion. The 
increased risk of severe complications in this population (haemorrhage, gastric perforation) 
is likely to mask important early symptomatic signs which make PUD treatment difficult in 
the elderly (Kemppainen et al., 1997). Most of the studies suggested that ulcer pain is less 
common in this age group. Indeed, the diagnosis of PUD is usually delayed, because 
symptoms are not easily detected in this population. Typical pain is often absent; only one 
third of people older than 60 years experience painful symptoms (Seinela&Ahvenainen, 
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2000). In geriatric practice, anorexia and malnutrition frequently represent alarm symptoms 
and lead to gastroduodenal endoscopy. Endoscopic exploration, which is most of the time 
well tolerated in elderly patients, allows a diagnosis in more than 50 percent of the cases 
(Van Kouwen et al., 2003). Another contributing factor to PUD in the elderly is a high usage 
of NSAIDs and/or aspirin. Pilotto et al. showed that NSAID use independently increases 
the risk of peptic ulcer and ulcer bleeding. This risk increases with age in a linear manner, 
and increases further in the event of comorbidities and polymedication which are common 
in this population (Pilotto et al., 2003). H. pylori infection also independently increases the 
risk of PUD in the elderly. Clinical studies reported that approximately 50 to 70 percent of 
elderly peptic ulcer patients are H. pylori positive (Pilotto, 2001). The short- and long-term 
studies performed on elderly patients demonstrated that treatment of H. pylori infection in 
patients with peptic ulcer resulted in ulcer healing in over 95 percent of the patients and 
significantly improved clinical outcomes, including a decrease in recurrence (Pilotto&Salles, 
2002). With regard to the respective responsibility of the two risk factors previously 
mentioned (AINS, H. pylori) in PUD, studies confirmed that both independently and 
significantly increase the risk of PUD and ulcer bleeding. 
4. H. pylori infection and gastric aging 
The ageing stomach is usually described in terms of the occurrence of gastric atrophic 
lesions. Thus, a wide range of studies reported an increased prevalence of atrophic gastritis 
in elderly patients, with rates ranging between 50 to 70% in patients over eighty (Sachs et al., 
2003; Younger&Duggan, 2002). Only a few studies provided results on intrinsic gastric 
ageing and most were animal studies. In contrast, most of the literature reported the strong 
role played by chronic H. pylori infection in the occurrence of atrophic gastric lesions. The 
discovery of H. pylori chronic infection has cast a doubt on the reality of the physiological 
gastric ageing process which is now considered as a process of “pathological gastric 
ageing”. Since the discovery of the strong role of this chronic gastric infection in the 
development of a gastric atrophy and PUD, we actually consider that most of the observed 
changes in the stomach that appear during ageing are, in fact, the result of environmental 
causes, such as chronic infection, nutritional, and pharmacological factors. These 
environmental factors may participate in inducing gastric frailty with impaired mucosal 
defence. 
4.1 Chronic atrophic gastritis 
A series of studies, mainly from Japan, has focused on the long-term effects of H. pylori 
infection and its role in the development of the histological changes that occur with ageing, 
i.e., atrophic gastritis (Salles, 2007). In a large multicenter trial, authors reported that both 
atrophic gastritis and intestinal metaplasia were strongly associated with H. pylori infection 
and not with ageing per se (Asaka et al., 2001). Interventional prospective studies reported 
that H. pylori eradication induces a significant reduction of inflammatory and atrophic 
gastric lesions (Ito et al., 2002; Kokkola et al., 2002). Kokkola et al. reported that advanced 
atrophic gastritis may improve and heal after H. pylori eradication in elderly subjects 
(Kokkola et al., 2002). They followed prospectively 22 elderly men (55–69 years of age) with 
H. pylori infection and atrophic corpus gastritis. During a 7.5-year period prior to eradication 
therapy, no significant changes were observed in the mean atrophy and IM scores. 
However, after H. pylori eradication, a significant improvement occurred in the mean 
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histological Sydney system score of inflammation (from 2.2 to 0.5), atrophy (from 2.2 to 1.2) 
and IM (from 1.6 to 1.1). These findings are in agreement with the results of another study 
carried out in 132 subjects aged from 34 to 68 years (mean age 50 years) with multifocal 
(nonautoimmune) atrophic gastritis. Six years after cure of H. pylori infection, a significant 
improvement in antral atrophy was detected in subjects who received anti-H. pylori 
treatment, the effect being greater among those who were free of infection at the end of the 
trial (Ruiz et al., 2001). Since the response to treatment was similar in patients of different 
ages, we may assume that the cure of H. pylori infection is as recommended in elderly 
patients with gastric mucosal modifications as it is for young and adult patients. During 
gastric ageing, histological modifications are frequently observed leading to physiological 
gastric disturbances. Thus, a high prevalence of chronic atrophic gastritis is frequently 
observed in the gastric mucosa of elderly people (Ofman et al., 2000; Pilotto, 2004). These 
histological lesions lead to hypochlorhydria with a risk of bacterial overgrowth in the 
proximal digestive tract and intestinal malabsorption. 
4.2 Gastric acid secretion 
Between 1920 and 1980, many studies reported a significant reduction in gastric acid 
secretion with age. The majority of these studies was retrospective and did not take into 
account the presence of possible gastric atrophic lesions (Salles, 2007). More recent studies 
including elderly patients showed that there is no change in acid secretion with age, 
whereas others even showed an increase in acid secretion. Those studies that demonstrate 
hyposecretion in elderly patients offer chronic H. pylori infection and atrophic gastritis of 
the oxyntic mucosa as a reasonable explanation. Shih et al. found that gastric acid secretion 
does not change with age (Shih et al., 2003). Feldman et al. studied gastric acid secretion in 
elderly patients and found that basal acid output and peak acid output did not correlate 
with age (Feldman&Cryer, 1998). Similarly, Lijima et al., reported that gastric acid secretion 
was well preserved irrespective of ageing, however it seemed to increase with ageing in the 
H. pylori-negative subjects (Iijima et al., 2004). The decline in gastric acid secretion in H. 
pylori-positive patients depends on both an increasing prevalence of fundic atrophic 
gastritis and inflammatory cytokines, i.e., interleukin (IL) IL-1 and TNF-, which are 
known to inhibit parietal cells. The mechanism promoting the increase in acid secretion with 
ageing is unknown. However, since the alteration of acid secretion by the inflammation of 
oxyntic mucosa can be ignored in the H. pylori-free stomach, two main possibilities could be 
considered: one is an increase in the total parietal cell mass with age, and the second is an 
increase in the reactivity of parietal cells. Because the previous studies failed to find any 
change in parietal cell mass with ageing, the second possibility is more likely. 
4.2.1 Gastrointestinal bacterial overgrowth 
Only a few clinical studies investigated the prevalence of gastrointestinal bacterial 
overgrowth in older healthy people, and most of the results showed that bacterial 
overgrowth occurs rarely during the normal process of gastric ageing, but is rather an 
iatrogenic process (antisecretory drugs) in the elderly. Mitsui et al. performed a study 
(Mitsui et al., 2006) and included healthy and disabled older people, aged over 70 years. 
They reported no bacterial overgrowth among healthy patients, but only in disabled or frail 
older people. Parlesak et al. also performed a study in older adults using a hydrogen breath 
test (Parlesak et al., 2003) and reported a 15.6% prevalence of small bowel bacterial 
overgrowth. They showed that PPI treatments played a role in increasing the prevalence of 
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positive breath tests in older adults, which was associated with lower body weight, lower 
body mass index, lower plasma albumin concentration, and higher prevalence of diarrhea. 
The pH of gastric acid and bacterial counts in the stomach showed a close correlation. In 
normal subjects the gastric pH is usually below pH 4, a critical level for protection against 
enteric pathogens, and the stomach is virtually sterile. At a pH of 4–5 bacteria from the 
saliva are present in the stomach. A pH greater than 5 allows bacterial, viral and protozoan 
pathogens to survive and enteric bacteria can be found in the stomach. Other drugs which 
decrease acid production are anticholinergic drugs and tricyclic antidepressant drugs. In 
geriatrics, malnutrition is one of the clinical consequences of bacterial overgrowth, and 
antibiotic treatment may lead to the improvement of the anthropometric parameters of these 
patients (Lewis et al., 1999). 
4.2.2 Vitamin B12 deficiency 
Cobalamin or vitamin B12 deficiency is common in elderly patients (Dali-Youcef&Andres, 
2009). The Framingham study demonstrated a prevalence of 12% among elderly people 
living in the community. Other studies focusing on elderly sick and malnourished people 
living in institutions have suggested a higher prevalence of 30–40%. The main causes of 
cobalamin deficiency include food-cobalamin malabsorption, pernicious anaemia, and 
insufficient nutritional vitamin B12. Dietary causes of deficiency are limited to elderly 
people who are already malnourished with lower albumin level, such as frail elderly 
patients with severe co morbidities (Salles-Montaudon et al., 2003). First described by 
Carmel in 1995, food-cobalamin malabsorption is frequent in elderly people, and is 
characterized by the inability of the body to release cobalamin from food or intestinal 
transport proteins, particularly in the presence of hypochlorhydria, where the absorption of 
‘unbound’ cobalamin is normal (Carmel et al., 2003). Food-cobalamin malabsorption is 
caused primarily by chronic atrophic gastritis. In fact, Andres et al, reported in a recent 
meta-analysis, that cobalamin deficiency, other than those caused by nutritional deficiency, 
can be treated by oral administration of vitamin B12 in the form of cyanocobalamin (free 
cobalamin) (Andres et al., 2009). An evidence-based analysis by the Vitamin B12 Cochrane 
Group also supports the efficacy of oral cobalamin therapy. In this analysis, serum vitamin 
B12 levels increased significantly in patients receiving either oral vitamin B12 alone or 
patients receiving both oral and intramuscular treatment (Vidal-Alaball et al., 2005). Other 
factors that contribute to food-cobalamin malabsorption in elderly people include chronic 
carriage of H. pylori and intestinal microbial proliferation, situations in which cobalamin 
deficiency can be corrected by antibiotic treatment, long-term ingestion of antiacids such as 
H2-receptor antagonists and PPI, and biguanides (metformin) (Dali-Youcef&Andres, 2009). 
Sipponen et al, reported normalization of vitamin B12 levels after H. pylori eradication 
(Sipponen et al., 2003). 
5. H. pylori infection and gastric cancer 
Gastric carcinoma and gastric MALT lymphoma have been causally associated with H. 
pylori, and the bacterium has been categorized as a group I carcinogen by the International 
Agency for Research on Cancer (IARC). The incidence of gastric cancer increases with age 
worldwide. However, the association between H. pylori infection and gastric cancer might 
have been underestimated due to possible clearance of the infection in the course of disease 
development, especially among older patients who generally have more severe mucosal 
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atrophy and intestinal metaplasia in the stomach. Recently, a new analytical investigation to 
minimize a potential underestimation of the association of H. pylori with gastric cancer was 
performed on Western populations [60]. Applying various more stringent exclusion criteria 
to minimize a potential bias from this source increased the odds ratio (95% confidence 
interval) of non-cardia gastric cancer from 3.7 to 18.3 for any H. pylori infection, and from 5.7 
to 28.4 for cagA-positive H. pylori infection (Brenner et al., 2004). A possible mechanism to 
explain the link between H. pylori infection and gastric carcinoma is inflammation which 
increases the risk of mutations. Many of the mediators and byproducts of inflammation are 
mitogenic and mutagenic. Release of pro-inflammatory cytokines, reactive oxygen species 
and upregulation of Cox-2 all contribute to an intragastric environment conducive to 
neoplastic transformation. The mechanisms involve direct DNA damage, inhibition of 
apoptosis, subversion of immunity, and stimulation of angiogenesis. In addition, chronic 
inflammation in the gastrointestinal tract is also known to affect proliferation, adhesion and 
cellular transformation. There is also evidence of a direct carcinogenic effect of H. pylori per 
se on the gastric mucosa. As mentioned before, the type 4 secretion system encoded by the 
cag PAI allows the bacterium to inject molecules into the epithelial cells. The CagA protein 
is one of them. It acts on numerous cell effectors disturbing cell physiology leading to 
several proneoplastic processes, e.g. activation of growth factor receptors, increased 
proliferation, evasion of apoptosis, sustained angiogenesis and cell dissociation, and tissue 
invasion. 
6. Impact of H. pylori infection on appetite regulation 
The results showed that the expression of leptin and ghrelin peptides decreased both in the 
presence of an H. pylori infection and in the presence of atrophic gastritis lesions. The 
possible role of H. pylori infection in the regulation of appetite in the elderly is an interesting 
new research topic. Studies reported that H. pylori eradication appeared to improve certain 
nutritional parameters, i.e., body mass index (BMI), and albumin (Azuma et al., 2002; 
Fujiwara et al., 2002). Kamada et al. recently showed a significant increase in the BMI after 
H. pylori eradication among patients suffering from gastric ulcers, with a parallel increase in 
triglyceride and cholesterol levels (Kamada et al., 2005). In geriatric practice, anorexia and 
weight loss are often the only symptoms of PUD and are signs warranting endoscopic 
exploration. It is also crucial to investigate H. pylori infection in such cases. Studies 
performed on adults indicate that inflammatory cytokines may cause anorexia by inducing 
variations in circulating gastrointestinal hormones, neuropeptides, and NO, all of which can 
alter food intake (Chapman, 2004; Morley, 2001). Recently, we showed that chronic 
inflammation in the gastric mucosa affects the expression of gastric satiety inducible 
peptides such as leptin and ghrelin (Salles et al., 2006). Recent evidence suggests that, in 
humans and rats, leptin is secreted not only from adipose tissue but also from the gut (Bado 
et al., 1998). Studies indicate that gastric inflammation induced by H. pylori infection raises 
gastric leptin expression which then induces satiety and lower BMI (Azuma et al., 2001; 
Konturek et al., 2001). Ghrelin is a newly discovered peptide which is produced mainly in 
the stomach and is involved in the control of food intake and energy homeostasis in both 
humans and rodents (Kojima et al., 1999). In a recent study, authors reported that a cure of 
H. pylori infection increased plasma ghrelin, which in turn led to an increased appetite and 
weight gain (Nwokolo et al., 2003). Consequently, chronic gastric inflammation may induce 
variations in the expression of both leptin and ghrelin and may play a role in the 
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pathophysiology of anorexia in elderly patients. In a study on frail elderly patients over 80 
years old, we showed that the presence of H. pylori chronic gastritis induced a decrease in 
both leptin and ghrelin gastric production; this finding may, in fact, be due to the high 
prevalence of atrophic lesions observed in this particular population (Salles et al., 2006). 
Furthermore, the presence of H. pylori chronic gastritis was negatively correlated to the 
caloric ratio and the body mass index of these aged patients. The decrease in plasmatic and 
gastric levels of the strong orexigen, ghrelin, could explain the lack of appetite and the 
malnutrition of aged people who have chronic gastritis lesions due to H. pylori 
7. H. pylori infection and Alzheimer's disease 
The risk factors identified for dementia are often inaccessible to intervention (age, gender, 
genetic). New hypotheses have recently been suggested, such as the possible relationship 
between H. pylori infection and dementia via inflammatory mechanisms, both pro-oxidant 
and carential. Indeed, in addition to two case-control studies pointing out an association 
between H. pylori infection and Alzheimer disease (Kountouras et al., 2006; Malaguarnera et 
al., 2004), an interventional study has shown that H. pylori eradication positively influences 
Alzheimer disease manifestations, especially cognitive decline (Kountouras et al., 2009). 
Preliminary results of a cohort study conducted in our laboratory concluded that H. pylori 
infection was a significant risk factor for developing Alzheimer disease. One of the 
hypothesis is that H. pylori infection could act as a trigger in the genesis or in the 
accumulation of Alzheimer disease lesions via cerebral hypoperfusion due to 
atherosclerosis, or via an exacerbation of neuroinflammation. 
8. Diagnosis of H. pylori infection in the elderly 
Diagnosis of H. pylori infection remains difficult in elderly patients because of the 
characteristics of this population. 
8.1 Non-invasive methods 
The advantage of these methods is that they are global tests, i.e., H. pylori can be detected 
even if the patchy distribution of the bacteria, when gastric atrophy is present, precludes 
their histological detection. 
8.1.1 Serology 
Generally speaking, H. pylori immunoglobulin G (IgG) antibodies appear 2 to 3 weeks 
following infection, and slowly decrease after H. pylori eradication. In adulthood, the 
performance of serology (ELISA) shows 85 to 95 percent sensitivity and 80 to 95 percent 
specificity (Granberg et al., 1993). Even if most of the epidemiologic studies included 
serology to detect H. pylori infection in the elderly, data concerning the performance of this 
test remain contradictory for this population. Some authors consider that there is a risk of 
over-estimating infection in the elderly when using serology, because antibodies remain 
present for months or even years after H. pylori eradication (Kosunen et al., 1992). Indeed, in 
this population, the prevalence of H. pylori infection is significantly higher when detected by 
serology than by histology. Studies reported that in H. pylori positive patients with atrophic 
body gastritis, after eradication therapy, the time delay concerning the decrease in H. pylori 
IgG did not always correlate with the reduction in gastric inflammation (Kosunen et al., 
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1992). This suggests that, in patients with atrophic body gastritis, serology alone may not be 
valid for assessing the efficacy of eradication treatment. Liston et al. showed that nearly one 
third of their study patients had positive serology without signs of active H. pylori infection 
(Liston et al., 1996). In addition, other authors reported that serology may not be useful in 
determining successful eradication post-therapy in the elderly, because of a great 
heterogeneity in the decrease in IgG antibody titer (6 months or more) (Kosunen et al., 1992). 
On the contrary, some authors consider that serology may underestimate the infection in the 
elderly. This could be explained by a possible lack of antibody response due to a frequent 
immunodeficiency diagnosed in frail elderly people. In fact, immunodeficiency may be the 
consequence of protein malnutrition which occurs in more than 30 percent of the elderly 
population (Burns, 2004; Salles-Montaudon et al., 2002). The infection could also be 
underestimated because of the characteristics of this elderly population, often hospitalized 
and treated with antibiotics for recurrent urinary tract or pulmonary infections which can 
induce false negative results. 
Immunoblot (Western blot) is another serologic method useful in the elderly, for the 
detection of antibodies directed against particular antigenic proteins of H. pylori (CagA, 
VacA, urease A and B). Pilotto et al. showed that the presence of a CagA positive H. pylori 
infection was independently correlated with atrophic gastritis and intestinal metaplasia in 
the elderly (Monteiro et al., 2002; Pilotto et al., 1998). 
8.1.2 13Carbon-Urea Breath Test 
The 13carbon-urea breath test (13C-UBT) has an excellent diagnostic performance including 
the post-therapy determination of successful H. pylori eradication. The principal 
disadvantage of this method is the need for specific equipment which associates gas 
chromatography and mass spectrometry. In the elderly, this test has the advantage of being 
easily performed with a minimum of cooperation from the patient, and it is very well 
tolerated. Pilotto et al. demonstrated the excellent performance of this test on elderly 
patients, with a diagnostic accuracy of 97.9%. They found it useful even for patients with 
severe cognitive impairment (Pilotto et al., 2000). In a recent study performed on 
hospitalized patients older than 85 years, we reported that almost one-third of the H. pylori-
positive patients would have remained undetected without this test, including treated 
patients (PPIs and antibiotics), or patients with chronic corpus atrophic gastritis [16]. Some 
studies reported the risk of an overestimation of H. pylori infection when using this test on 
the elderly. This could be explained by a hypochlorhydria due to gastric atrophy, which 
allows gastric colonization by urease-producing bacteria present in the mouth, oropharynx, 
and small intestine and decreases the specificity of the test (Chen et al., 2000). Certain 
situations can, to the contrary, involve an underestimation of H. pylori diagnosis in older 
subjects. Among these various cases, a past gastric resection may decrease the amount of 
urea present in the stomach, leading to an insufficient H. pylori detection. 
8.1.3 Stool test 
One of the formats of this test is a microwell-based immunoassay (HpSA), which detects H. 
pylori antigens present in human stools (Vaira et al., 1999). This test has a good diagnostic 
performance and can be easily carried out in routine. The test’s lower sensitivity in the 
elderly can be explained by the higher frequency of chronic constipation in this group. 
Indeed, the passage of the bacteria into the colon may be prolonged, leading to a 
degradation of H. pylori antigens and jeopardizing their detection. This has been shown 
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experimentally in stools spiked with H. pylori. Moreover, studies have shown that PPI 
treatment decreases the accuracy of HpSA by increasing the gastric pH and suppressing H. 
pylori colonization (Monteiro et al., 2001). The HpSA test also presents the disadvantage of 
being more difficult to carry out in this very old population, mainly for practical reasons, in 
dependent or demented older subjects (Salles-Montaudon et al., 2002). 
8.2 Invasive methods 
Most of the time, older patients have diagnostic indications for upper gastrointestinal 
endoscopy, i.e., chronic anemia, dysphagia, epigastralgia, etc. Biopsy sampling per 
endoscopy permits the detection of H. pylori infection by urease test, histological analysis, 
culture or PCR. 
8.2.1 Biopsy urease test 
There are several tests available based on the the urease activity of H. pylori present in 
biopsy specimens, among which are the CLO test® and the PyloriTek®. In the elderly, 
studies reported a lower sensitivity of these tests (57%) compared to histology or serology 
(Abdalla et al., 1998). As stated previously, the lower sensitivity can be explained by 
multiple treatments for various infections, and frequent gastric atrophic lesions which may 
induce a hostile environment for the bacterium. 
8.2.2 Histology 
In the elderly, the performance of this test increased when biopsy specimens were taken 
from two areas of the stomach, i.e., the antrum and the body. Indeed, chronic gastric 
atrophy may induce gastric hypochlorhydria which may in turn reduce H. pylori 
colonization in the antrum. In the elderly, a histological analysis should not be the only 
diagnostic method for H. pylori infection, because of its lower sensitivity as previously 
stated. 
Nevertheless, this method presents the advantage of evaluating the morphological 
parameters of the gastric mucosa, using the Sydney System classification suggested in 1990 
by Price et al. (Price, 1991). The revised classification made in 1994 in Houston is now 
widely accepted (Genta&Dixon, 1995). These criteria are studied and quantified as either 
mild, moderate or severe: activity, inflammation, atrophy, intestinal metaplasia, and the 
presence of H. pylori infection. Given the increased incidence of malignancy in the elderly 
population, histology has become mandatory. 
8.2.3 Culture 
Microbiological examination of biopsy specimens is considered as the reference technique. 
Culture provides unique information which is helpful in the management of H. pylori 
infection, in particular the strain’s susceptibility to antimicrobial agents (Mégraud, 1996). 
Concerning all of the “invasive methods”, they may underestimate H. pylori infection in the 
elderly because of the frequent antibiotic and PPI treatments, and also the high prevalence 
of chronic atrophy lesions. 
8.2.4 Molecular methods 
Molecular diagnosis of H. pylori infection presents a real interest. PCR detection of H. pylori 
in gastric biopsies offers very sensitive and accurate results in a short time. Many protocols 
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have been developed for targeting different genes with specific primers for H. pylori. 
Recently, realtime PCR assays were developed allowing simultaneous detection and 
quantification as well as the determination of antibiotic susceptibility and genotyping of H. 
pylori (Oleastro et al., 2003). 
9. Indications for treatment in geriatrics 
9.1 Peptic ulcer disease 
The short- and long-term studies performed on elderly patients indicate that treatment of H. 
pylori infection in patients with peptic ulcers results in healed ulcers in over 95% of the 
patients, and significantly improves the clinical outcome, reducing ulcer recurrence, and 
histological signs of ulcer-associated chronic gastritis activity [13,86]. It is, thus, strongly 
recommended to test and treat H. pylori infection among the elderly presenting peptic 
ulcers. Pilotto et al. showed that the rate of peptic ulcer relapse in eradicated older patients 
was 2 percent versus 42 percent in those non-eradicated (Pilotto, 2001). 
9.2 Atrophic chronic gastritis 
As stated previously, H. pylori eradication induces a decrease in the severity of gastric 
inflammation, atrophy and intestinal metaplasia (Kokkola et al., 2002). The Maastricht 2-
2000 Consensus Report recommends treating patients with atrophic gastritis (Malfertheiner 
et al., 2002). 
9.3 Non-ulcer dyspepsia 
The effectiveness of H. pylori eradication in patients with non-ulcer dyspepsia is still a 
matter of debate. A study carried out on a geriatric population showed a significant 
improvement in symptoms of functional dyspepsia in 70% of the patients two months after 
eradication (Pilotto et al., 1999). However, the long-term benefit was not studied. 
9.4 Gastroesophageal reflux disease 
The relationship between H. pylori infection and the clinical evolution of gastroesophageal 
reflux disease has not yet been clarified in elderly subjects (Kountouras et al., 2004; 
Kountouras et al., 2006). In a study carried out on elderly patients with esophagitis, Pilotto 
et al. reported that healing of esophagitis after a 2 month treatment with PPIs was similar in 
H. pylori-positive and H. pylori-negative patients (Pilotto et al., 2002). Moreover, eradication 
therapy did not accelerate the clinical response to short-term PPI therapy among these 
patients. H. pylori eradication is thus not recommended for elderly patients with 
gastroesophageal reflux disease. 
9.5 Use of non-steroidal anti-inflammatory drugs 
It is now established that most peptic ulcers are caused by H. pylori or NSAIDs. Studies 
showed that H. pylori eradication is not sufficient in preventing ulcer bleeding in high-risk 
NSAID users (Chan et al., 2002; Lai et al., 2003; Pilotto et al., 2000a). It does not enhance the 
healing of peptic ulcer in patients taking antisecretory therapy who continue to take 
NSAIDs. However, PPI was superior to the eradication of H. pylori in preventing recurring 
bleeding in patients who are taking NSAIDs.  
Among patients with H. pylori infection and a history of upper gastrointestinal bleeding 
who are taking low-dose aspirin, the eradication of H. pylori is equivalent to treatment with 
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omeprazole in preventing recurrent bleeding (Chan et al., 2001). In conclusion, there is no 
clear proof which supports the systematic eradication of H. pylori in elderly patients treated 
with short- or long-term aspirin and/or NSAID drugs. 
10. H. pylori eradication in geriatrics 
Many clinical trials demonstrated that PPI-based triple therapies for 1 week, as 
recommended by the Maastricht 2-2000 Consensus Report, were highly effective in the 
elderly population (Pilotto&Malfertheiner, 2002). H. pylori eradication is more effective in 
elderly people compared to younger individuals. Studies performed on elderly patients also 
showed that a reduction in the PPI dosage, i.e. omeprazole (20 mg) and pantoprazole (40 
mg), from twice daily to once daily did not influence the cure rates of triple therapies 
consisting of either PPI plus clarithromycin (250 mg b.i.d.) and metronidazole (500 mg 
b.i.d.), or PPI plus clarithromycin (250 mg b.i.d.) and amoxicillin (1 g b.i.d.) (Pilotto et al., 
2001; Pilotto&Malfertheiner, 2002; Pilotto&Salles, 2002). 
Bad compliance, which is frequently observed in elderly subjects, and H. pylori resistance to 
antibiotics, are the major reasons for treatment failure in elderly patients (Pilotto&Salles, 
2002). Studies reported that metronidazole resistance decreased with age (OR for patients 
over 60 years = 0.63, 95% CI = 0.48–0.80) and was higher in females than in males 
(Pilotto&Salles, 2002). The optimal strategy for second-line therapy associates PPI with 
amoxicillin and metronidazole or PPI with tetracycline and metronidazole, with a 
recommendation to increase the duration of treatment (10 to 14 days) as well as the 
metronidazole doses. Concerning the poor compliance in older patients, the use of 
structured patient counselling and follow-up may have a significant effect on H. pylori cure 
rates and should be part of therapy management. 
11. Conclusion 
The strongest prevalence of H. pylori infection in the elderly as well as the role of H. pylori in 
the occurrence of gastric lesions, in particular ulcer diseases, gastric precancerous lesions, 
and gastric cancer, render the diagnosis and the eradication of H. pylori capital in this 
population. However, studies evaluating the prevalence, diagnosis and treatment of this 
infection are still few concerning this population, especially in frail patients older than 80 
years. 
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